https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Antibody-Drug Conjugates Poised to Revolutionize Treatment of Urothelial Carcinoma

Antibody-Drug Conjugates Poised to Revolutionize Treatment of Urothelial Carcinoma

Enfortumab vedotin is one of many effective antibody-drug conjugates on the market that can be utilized to improve the treatment of urothelial carcinoma.

administrator

Related Articles